Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Specialty Chemicals

Kensing buying Evonik plant

by Alexander H. Tullo
August 8, 2022 | A version of this story appeared in Volume 100, Issue 27

 

Kensing has agreed to acquire Evonik Industries’ amphoteric surfactant and specialty ester plant in Hopewell, Virginia. The acquisition is the second one that Kensing, backed by the private equity firm One Rock Capital Partners, has made recently. In June, Kensing bought the Spanish firm Vitae Naturals, which makes vitamin E–derived food ingredients and cosmetics. Kensing was formed in 2021 when One Rock bought a BASF plant in Kankakee, Illinois, that makes sterols, vitamin E, and anionic surfactants. Kensing says the purchase of the Evonik plant will give it a strong position in betaine chemistry.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.